Metrics as of 10/17/2026, 03:35 AM (Berlin time), refresh in progress.
Edwards Lifesciences Stock
Edwards Lifesciences Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Bernard J. Zovighian
- Employees
- 16,000
- Market cap
- $49.9 B
- IPO
- 27/03/2000
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. Founded in 1958, the company is headquartered in Irvine, USA, and operates across the United States,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Edwards Lifesciences stock: price history
1D
-1.7%
1W
+1.6%
1M
-3.0%
6M
+6.9%
YTD
+1.6%
1Y
+19.2%
2Y
+26.8%
5Y
-22.8%
10Y
+124.0%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~121% stronger price swings than usual
Ask the agents about Edwards Lifesciences
Analyst assessment of Edwards Lifesciences
PRICE TARGET LOW
US$85.00
CONSENSUS
US$102.44
MEDIAN
US$101.00
PRICE TARGET HIGH
US$110.00
0
STRONG BUY
33
BUY
16
HOLD
0
SELL
0
STRONG SELL
49
TOTAL · Buy
As of: 11/09/2026
Edwards Lifesciences stock metrics
P/E
49.77
P/B
4.7
EV/EBITDA
30.14
RETURN ON EQUITY
2.3%
NET MARGIN
13.9%
DEBT/EQUITY
0.07
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.8%
FLOAT SHARES
569,383,483
AVG. DAILY VOLUME (30D)
3,675,019
Insider transactions (SEC)
Lippis Daniel J.
Lippis Daniel J.
Dahl Andrew M.
Markowitz Wayne
Markowitz Wayne
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.7%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Edwards Lifesciences stock
What does Edwards Lifesciences do?
Edwards Lifesciences Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Bernard J. Zovighian, the company employs around 16,000 people.
The IPO was on 27/03/2000; the stock trades on NYSE under the ticker EW.
What do analysts say about Edwards Lifesciences stock?
49 analysts rate the stock, the consensus is Buy (as of 11/09/2026).
The average price target is US$102.44, ranging from US$85.00 to US$110.00, with a median of US$101.00.
This is an external assessment, not a statement by Market Jury.
When does Edwards Lifesciences report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 121% stronger than usual.
Does Edwards Lifesciences pay a dividend?
No, Edwards Lifesciences currently does not pay a dividend.
Which stocks are comparable to Edwards Lifesciences?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings, Align Technology and Bio-Rad Laboratories.
How can I get Edwards Lifesciences stock analyzed?
Clicking "Analyze stock" lets five strategies assess Edwards Lifesciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.